Planning a medical device trial in Canada? Securing an Investigational Testing Authorization (ITA) is a crucial regulatory milestone for Class II–IV devices—but it comes with challenges, from limited Health Canada guidance to regional REB variations and complex operational demands.

Hosted by Medtech Canada on September 19, 2025, join Vatche Bartekian, President of Vantage BioTrials, and his co-presenter Marie-Claude Gravel, President of SPharm, as they explore the regulatory and clinical hurdles sponsors face when initiating investigational device studies in Canada—and how to overcome them.

This webinar is a must-attend for industry sponsors, clinical teams, and regulatory professionals navigating the Canadian medical device landscape.

For more information on how Vantage BioTrials can support your next trial, contact us at [email protected].